By Josh Beckerman
Hinge Health shares opened at $39.25 Thursday on the New York Stock Exchange after its initial public offering of 13.67 million shares priced at $32 each.
The IPO's estimated price range was $28 to $32.
The virtual physical therapy company is selling 8.52 million of the shares, with the other 5.14 million offered by stockholders including Insight Partners, Atomico and 11.2 Capital.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
By Josh Beckerman
Shares of Hinge Health rose in their New York Stock Exchange debut, one of several favorable signals for an initial public offering market that stalled in early April.
The virtual physical therapy company's stock opened at $39.25 on Thursday and were recently at $38.22 midday. The IPO of 13.67 million shares priced at $32 each, compared with an estimated price range was $28 to $32.
The San Francisco company is selling 8.52 million of the shares, with the other 5.14 million offered by stockholders such as Insight Partners, Atomico and 11.2 Capital.
Meanwhile, MNTN Inc. shares were up 50%, to $24, following their debut earlier Thursday. MNTN, a software platform for connected TV advertising, said Wednesday that its 11.7 million-share IPO priced at $16 a share. The expected range was $14 to $16 apiece for the Austin, Texas, company's shares.
Qualcomm had a pre-IPO stake in MNTN of about 15%.
After a stock selloff linked to tariff concerns, The Wall Street Journal reported April 4 that ticketing marketplace StubHub and buy-now-pay-later company Klarna were postponing IPO roadshows.
Earlier this month, trading platform eToro Group's IPO was upsized and priced above its expected range. Aspen Insurance upsized its IPO, which priced in the middle of its expected range. Multiple blank-check companies have also started trading with increased IPO sizes this month.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
May 22, 2025 14:30 ET (18:30 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。